Profile data is unavailable for this security.
About the company
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.
- Revenue in SEK (TTM)137.00k
- Net income in SEK-97.60m
- Incorporated2000
- Employees6.00
- LocationAbliva ABMedicon Village, Scheeletorget 1LUND 223 81SwedenSWE
- Phone+46 462756220
- Fax+46 468888348
- Websitehttps://abliva.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exact Therapeutics AS | 0.00 | -47.41m | 224.98m | 8.00 | -- | 5.09 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
Thor Medical ASA | 0.00 | -5.45m | 236.35m | 1.00 | -- | 0.8812 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Lumito AB (publ) | 17.00k | -25.67m | 252.39m | 14.00 | -- | 2.32 | -- | 14,846.28 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
Intervacc AB | 8.93m | -102.77m | 265.08m | 15.00 | -- | 1.20 | -- | 29.70 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Ultimovacs ASA | 0.00 | -174.47m | 278.08m | 25.00 | -- | 1.09 | -- | -- | -5.17 | -5.17 | 0.00 | 7.53 | 0.00 | -- | -- | 0.00 | -44.31 | -28.80 | -50.09 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
Acousort AB | 4.29m | -17.78m | 287.48m | -- | -- | 14.39 | -- | 66.95 | -1.25 | -1.25 | 0.3048 | 1.34 | 0.1595 | 4.59 | 4.21 | -- | -66.05 | -48.62 | -99.10 | -69.77 | -117.16 | -68.05 | -414.04 | -299.58 | 2.72 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
Abliva AB | 137.00k | -97.60m | 329.92m | 6.00 | -- | 4.88 | -- | 2,408.21 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -21,359.13 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
Medivir AB | 7.73m | -96.52m | 334.26m | 10.00 | -- | 1.58 | -- | 43.23 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
Lifecare ASA | 12.84m | -34.58m | 337.12m | 32.00 | -- | 4.23 | -- | 26.26 | -0.2454 | -0.2454 | 0.092 | 0.4163 | 0.1621 | -- | 4.90 | 408,943.10 | -43.60 | -40.00 | -49.97 | -45.26 | -- | -- | -269.03 | -175.53 | -- | -- | 0.1812 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
Curasight A/S | -44.76m | -46.14m | 344.17m | 4.00 | -- | 9.36 | -- | -- | -1.47 | -1.47 | -1.43 | 1.18 | -0.6914 | -- | -- | -7,114,500.00 | -71.27 | -24.61 | -77.08 | -26.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -123.97 | -- | -42.62 | -- | -- | -- |
Guard Therapeutics Intrntnl AB (publ) | 0.00 | -87.91m | 349.62m | 6.00 | -- | 5.50 | -- | -- | -8.74 | -8.74 | 0.00 | 5.27 | 0.00 | -- | -- | -- | -75.10 | -69.56 | -91.32 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
SynAct Pharma AB | 0.00 | -190.84m | 350.61m | 5.00 | -- | 1.98 | -- | -- | -5.65 | -5.65 | 0.00 | 4.28 | 0.00 | -- | -- | 0.00 | -71.43 | -125.17 | -79.52 | -151.70 | -- | -- | -- | -- | -- | -853.13 | 0.0033 | -- | -- | -- | -117.54 | -- | -- | -- |
Herantis Pharma Oyj | 0.00 | 3.29m | 363.32m | 10.00 | 122.12 | 6.55 | 110.59 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
Xbrane Biopharma AB | 190.97m | -361.27m | 389.25m | 75.00 | -- | 0.9877 | -- | 2.04 | -1.33 | -1.58 | 0.6978 | 0.2577 | 0.2465 | 1.34 | 332.12 | 2,053,430.00 | -46.63 | -40.98 | -78.01 | -67.24 | 15.43 | -- | -189.18 | -364.40 | 1.43 | -31.13 | 0.3693 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
Annexin Pharmaceuticals AB (publ) | 0.00 | -52.36m | 409.33m | 4.00 | -- | 11.36 | -- | -- | -0.1873 | -0.1873 | 0.00 | 0.0676 | 0.00 | -- | -- | 0.00 | -162.59 | -125.42 | -220.41 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
Mendus AB (publ) | 0.00 | -107.06m | 410.43m | 28.00 | -- | 0.5233 | -- | -- | -1.59 | -1.59 | 0.00 | 15.57 | 0.00 | -- | -- | 0.00 | -16.09 | -18.84 | -17.35 | -20.21 | -- | -- | -- | -28,474.53 | -- | -150.86 | 0.0348 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
Data as of Jul 26 2024. Currency figures normalised to Abliva AB's reporting currency: Swedish Krona SEK
1.54%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Handelsbanken Fonder ABas of 30 Jun 2024 | 6.94m | 0.51% |
Skandia Investment Management ABas of 31 May 2024 | 6.67m | 0.49% |
SEB Investment Management ABas of 28 Jun 2024 | 3.45m | 0.26% |
FCG Fonder ABas of 31 Dec 2023 | 2.68m | 0.20% |
Storebrand Asset Management ASas of 30 Jun 2024 | 811.31k | 0.06% |
Skandia Fonder ABas of 31 May 2024 | 245.36k | 0.02% |
More ▼
Data from 29 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.